TGA still hasn't released the post-market sensitivity evaluation of rapid antigen tests against omicron.
Only one point of care (not self-) test appears to have had its approval suspended so far.
https://t.co/db2PlpSuBo
Wholeheartedly agree with this change of terminology!
"Fully vaccinated" implies you're done, whereas the reality is that against omicron a waned second dose is closer to unvaccinated than boosted.
Omicron won't be the last.
Boost will wane.
https://t.co/EyQKTvsCLP
@Rural_RN@ToshiAkima@ketaminh@DocOnSkis @CdrHBiscuitIII @EBMgoneWILD Hasn't been available locally. It's the 604. For the 6000 series. You'd need to find somewhere that ships to Australia, and probably pay maybe USD 50 to get it.
https://t.co/twl5jjyZBZ
@DanDbab Why is HR higher for 3 dose vs <2 than 2 dose vs <2 when they're are fewer % severe outcomes across the board for 3 dose? Am I missing something here?
@CrabbBrendan @Princelysum Disaggregated the daily cases by sequencing data estimating daily BA.1, BA.2, BA.1.1 a little while ago.
It was absolutely growing well past BA.1 could get near. Previously thought maybe reinfection advantage, but I think much more likely R0 is higher:
https://t.co/phTtmp6xlr